PROFILE - Evaluation of QoL and PRO Outcomes in Patients Taking Fingolimod

Clinical trial NCT02335892 · COMPLETED

Trial details

NCT number: NCT02335892
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2014-11-11
Primary completion: 2017-02-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.